IN2012DE01754A - - Google Patents

Info

Publication number
IN2012DE01754A
IN2012DE01754A IN1754DE2012A IN2012DE01754A IN 2012DE01754 A IN2012DE01754 A IN 2012DE01754A IN 1754DE2012 A IN1754DE2012 A IN 1754DE2012A IN 2012DE01754 A IN2012DE01754 A IN 2012DE01754A
Authority
IN
India
Prior art keywords
bioactives
antimicrobials
perfumes
flavors
ointments
Prior art date
Application number
Other languages
English (en)
Inventor
Guruswamy Kumaraswamy
Edakkal Venugopal
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to EP13739817.8A priority Critical patent/EP2858627B1/en
Priority to IN1754DE2012 priority patent/IN2012DE01754A/en
Priority to US14/406,037 priority patent/US9421270B2/en
Priority to PCT/IN2013/000360 priority patent/WO2013183068A1/en
Publication of IN2012DE01754A publication Critical patent/IN2012DE01754A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/652—The particulate/core comprising organic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN1754DE2012 2012-06-07 2013-06-07 IN2012DE01754A (cg-RX-API-DMAC7.html)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP13739817.8A EP2858627B1 (en) 2012-06-07 2013-06-07 Surfactant-copolymer complexes useful for sustained drug release
IN1754DE2012 IN2012DE01754A (cg-RX-API-DMAC7.html) 2012-06-07 2013-06-07
US14/406,037 US9421270B2 (en) 2012-06-07 2013-06-07 Surfactant-copolymer complexes useful for sustained drug release
PCT/IN2013/000360 WO2013183068A1 (en) 2012-06-07 2013-06-07 Surfactant-copolymer complexes useful for sustained drug release

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1754DE2012 IN2012DE01754A (cg-RX-API-DMAC7.html) 2012-06-07 2013-06-07

Publications (1)

Publication Number Publication Date
IN2012DE01754A true IN2012DE01754A (cg-RX-API-DMAC7.html) 2015-10-02

Family

ID=48832972

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1754DE2012 IN2012DE01754A (cg-RX-API-DMAC7.html) 2012-06-07 2013-06-07

Country Status (4)

Country Link
US (1) US9421270B2 (cg-RX-API-DMAC7.html)
EP (1) EP2858627B1 (cg-RX-API-DMAC7.html)
IN (1) IN2012DE01754A (cg-RX-API-DMAC7.html)
WO (1) WO2013183068A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228610C (en) 1995-08-17 2008-06-03 Heidi Rolfes Controlled release products
US5690911A (en) 1996-06-07 1997-11-25 Colgate Palmolive Company Oral composition containing a mixed surfactant system for promoting antibacterial compound uptake on dental tissue
TW201111457A (en) 2009-06-10 2011-04-01 Glaxosmithkline Llc Novel article

Also Published As

Publication number Publication date
EP2858627A1 (en) 2015-04-15
WO2013183068A4 (en) 2014-08-07
EP2858627B1 (en) 2019-05-01
US9421270B2 (en) 2016-08-23
WO2013183068A9 (en) 2014-06-12
US20150174251A1 (en) 2015-06-25
WO2013183068A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
PH12016500316A1 (en) Improved adenovirus formulations
SG11201604660VA (en) Drug delivery system.
EP3265064A4 (en) Drug delivery device
EP3378482A4 (en) FORMULATION FOR ADMINISTRATION OF ANTIMORALS
EP3129065A4 (en) Targeted drug delivery through affinity based linkers
EP3532131A4 (en) PORTABLE MEDICINE DISPENSER
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
EP3025705B8 (en) Stable ivabradine formulations
EP3275452A4 (en) Pharmaceutical composition containing silibinin
MY183068A (en) Pharmaceutical formulation comprising antibody
AU2016361427A8 (en) Platinum anticancer agents
EP3207036A4 (en) Novel small molecule anticancer agents
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
BR112014032501A2 (pt) composto, e, composição farmacêutica.
EP3181137A4 (en) Pharmaceutical composition for preventing or treating gleevec-resistant leukemia, containing, as active ingredient, ginsenoside f1 or rg3
EP3154524A4 (en) Extended-release drug delivery compositions
MY165088A (en) Pharmaceutical compositions comprising alisporivir
EP3225255A4 (en) Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system
HK1215571A1 (zh) 二盐酸科比思特
EP3650484A4 (en) ACTIVE SUBSTANCE RELEASE CARRIERS DIRECTED TO THE KIDNEYS
EP3256092A4 (en) Drug dispenser
IL250913B (en) Platinum (iv) complexes, preparations containing them and their uses
EP3291838A4 (en) Anionic nanoparticles for use in the delivery of anionic small molecule drugs
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE